Celator Pharmaceuticals (CPXX) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts CPXX Hot Sheet
Join SI Premium – FREE
Celator Pharmaceuticals (NASDAQ: CPXX) reported Q2 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14).
For earnings history and earnings-related data on Celator Pharmaceuticals (CPXX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
